Logo image of ULBI

ULTRALIFE CORP (ULBI) Stock Fundamental Analysis

USA - NASDAQ:ULBI - US9038991025 - Common Stock

6.75 USD
-0.12 (-1.75%)
Last: 11/7/2025, 8:23:40 PM
Fundamental Rating

5

Taking everything into account, ULBI scores 5 out of 10 in our fundamental rating. ULBI was compared to 92 industry peers in the Electrical Equipment industry. ULBI has only an average score on both its financial health and profitability. ULBI may be a bit undervalued, certainly considering the very reasonable score on growth This makes ULBI very considerable for value investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ULBI was profitable.
In the past year ULBI had a positive cash flow from operations.
In multiple years ULBI reported negative net income over the last 5 years.
ULBI had a positive operating cash flow in 4 of the past 5 years.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

ULBI has a Return On Assets of 1.45%. This is in the better half of the industry: ULBI outperforms 70.65% of its industry peers.
With a decent Return On Equity value of 2.31%, ULBI is doing good in the industry, outperforming 69.57% of the companies in the same industry.
ULBI has a better Return On Invested Capital (3.75%) than 68.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ULBI is significantly below the industry average of 10.26%.
The last Return On Invested Capital (3.75%) for ULBI is above the 3 year average (3.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.45%
ROE 2.31%
ROIC 3.75%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ULBI has a better Profit Margin (1.79%) than 70.65% of its industry peers.
In the last couple of years the Profit Margin of ULBI has declined.
The Operating Margin of ULBI (5.14%) is better than 70.65% of its industry peers.
ULBI's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 24.39%, ULBI is in line with its industry, outperforming 48.91% of the companies in the same industry.
In the last couple of years the Gross Margin of ULBI has declined.
Industry RankSector Rank
OM 5.14%
PM (TTM) 1.79%
GM 24.39%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ULBI is destroying value.
Compared to 1 year ago, ULBI has more shares outstanding
Compared to 5 years ago, ULBI has more shares outstanding
ULBI has a worse debt/assets ratio than last year.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

ULBI has an Altman-Z score of 1.95. This is not the best score and indicates that ULBI is in the grey zone with still only limited risk for bankruptcy at the moment.
ULBI has a Altman-Z score of 1.95. This is in the better half of the industry: ULBI outperforms 61.96% of its industry peers.
ULBI has a debt to FCF ratio of 3.67. This is a good value and a sign of high solvency as ULBI would need 3.67 years to pay back of all of its debts.
ULBI has a Debt to FCF ratio of 3.67. This is in the better half of the industry: ULBI outperforms 77.17% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that ULBI is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.34, ULBI perfoms like the industry average, outperforming 51.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.67
Altman-Z 1.95
ROIC/WACC0.51
WACC7.4%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

ULBI has a Current Ratio of 3.31. This indicates that ULBI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ULBI (3.31) is better than 78.26% of its industry peers.
A Quick Ratio of 1.62 indicates that ULBI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.62, ULBI is in the better half of the industry, outperforming 64.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 1.62
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ULBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.61%.
Measured over the past 5 years, ULBI shows a small growth in Earnings Per Share. The EPS has been growing by 3.31% on average per year.
The Revenue has been growing slightly by 5.86% in the past year.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)-67.61%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-68.18%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%12.98%

3.2 Future

Based on estimates for the next years, ULBI will show a very strong growth in Earnings Per Share. The EPS will grow by 43.60% on average per year.
The Revenue is expected to grow by 18.34% on average over the next years. This is quite good.
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.35, which means the current valuation is very expensive for ULBI.
Compared to the rest of the industry, the Price/Earnings ratio of ULBI indicates a somewhat cheap valuation: ULBI is cheaper than 75.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.83, ULBI is valued at the same level.
Based on the Price/Forward Earnings ratio of 7.12, the valuation of ULBI can be described as very cheap.
98.91% of the companies in the same industry are more expensive than ULBI, based on the Price/Forward Earnings ratio.
ULBI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 32.68.
Industry RankSector Rank
PE 29.35
Fwd PE 7.12
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

91.30% of the companies in the same industry are more expensive than ULBI, based on the Enterprise Value to EBITDA ratio.
ULBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ULBI is cheaper than 98.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.08
EV/EBITDA 10.91
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ULBI's earnings are expected to grow with 43.60% in the coming years.
PEG (NY)0.43
PEG (5Y)8.88
EPS Next 2Y43.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ULBI!.
Industry RankSector Rank
Dividend Yield N/A

ULTRALIFE CORP

NASDAQ:ULBI (11/7/2025, 8:23:40 PM)

6.75

-0.12 (-1.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)10-23 2025-10-23
Earnings (Next)03-09 2026-03-09
Inst Owners71.63%
Inst Owner Change-1.1%
Ins Owners3.17%
Ins Owner Change1.44%
Market Cap112.32M
Revenue(TTM)178.85M
Net Income(TTM)3.20M
Analysts82.86
Price Target14.28 (111.56%)
Short Float %0.85%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-33.01%
Min EPS beat(2)-50.98%
Max EPS beat(2)-15.03%
EPS beat(4)0
Avg EPS beat(4)-62.53%
Min EPS beat(4)-93.46%
Max EPS beat(4)-15.03%
EPS beat(8)3
Avg EPS beat(8)0.49%
EPS beat(12)5
Avg EPS beat(12)43.66%
EPS beat(16)7
Avg EPS beat(16)37.65%
Revenue beat(2)1
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-6.65%
Max Revenue beat(2)3.65%
Revenue beat(4)2
Avg Revenue beat(4)-3.53%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)7.48%
Revenue beat(8)5
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)3.79%
Revenue beat(16)10
Avg Revenue beat(16)3.23%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 29.35
Fwd PE 7.12
P/S 0.63
P/FCF 8.08
P/OCF 6.57
P/B 0.81
P/tB 1.62
EV/EBITDA 10.91
EPS(TTM)0.23
EY3.41%
EPS(NY)0.95
Fwd EY14.05%
FCF(TTM)0.84
FCFY12.38%
OCF(TTM)1.03
OCFY15.22%
SpS10.75
BVpS8.32
TBVpS4.16
PEG (NY)0.43
PEG (5Y)8.88
Graham Number6.56
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 2.31%
ROCE 4.81%
ROIC 3.75%
ROICexc 3.98%
ROICexgc 6.46%
OM 5.14%
PM (TTM) 1.79%
GM 24.39%
FCFM 7.77%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)5.27%
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y2.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.19%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
F-Score3
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.67
Debt/EBITDA 3.36
Cap/Depr 64.6%
Cap/Sales 1.79%
Interest Coverage 250
Cash Conversion 120.88%
Profit Quality 434.92%
Current Ratio 3.31
Quick Ratio 1.62
Altman-Z 1.95
F-Score3
WACC7.4%
ROIC/WACC0.51
Cap/Depr(3y)49.8%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.61%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-68.18%
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.86%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%12.98%
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.21%
EBIT growth 3YN/A
EBIT growth 5Y8.76%
EBIT Next Year101.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3132.56%
FCF growth 3Y113.07%
FCF growth 5YN/A
OCF growth 1Y575.69%
OCF growth 3Y56.62%
OCF growth 5YN/A

ULTRALIFE CORP / ULBI FAQ

What is the ChartMill fundamental rating of ULTRALIFE CORP (ULBI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ULBI.


Can you provide the valuation status for ULTRALIFE CORP?

ChartMill assigns a valuation rating of 8 / 10 to ULTRALIFE CORP (ULBI). This can be considered as Undervalued.


Can you provide the profitability details for ULTRALIFE CORP?

ULTRALIFE CORP (ULBI) has a profitability rating of 5 / 10.


How financially healthy is ULTRALIFE CORP?

The financial health rating of ULTRALIFE CORP (ULBI) is 5 / 10.